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On the basis of both the interleukin-2-receptor (IL-2R) a-chain expression on 16-day-old fetal
rat thymocytes and the occurrence of interleukin-2 (IL-2) mRNA-containing cells early during
rat thymus ontogeny, we have investigated the possible role of IL-2/IL-2R complex in rat T-cell
maturation. For this purpose, we analyzed the effects of the addition of either recombinant rat IL-
2 or anti-CD25 (OX-39)-blocking monoclonal antibodies to fetal thymus organ cultures (FTOC),
established from 16-day-old rat embryos. IL-2 stimulated the growth of thymocytes and, as a
result, induced T-cell differentiation, whereas OX-39 mAb blocked the maturation of thymic-cell
progenitors. Accordingly, these results support the involvement of IL-2/IL-2R complex in rat T-
cell development.
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INTRODUCTION
It is now accepted that interleukin-2 (IL-2) is a potent
growth factor for mature T cells. However, much
controversy has arisen concerning its role, if any, in
the first stages of T-cell development. The expression
of individual chains (or,/3, and y) of the IL-2 receptor
(IL-2R) on immature thymocytes (Ceredig et al.,
1985; Toribio et al., 1989; Kondo et al., 1994; Reya et
al., 1996), as well as the ability of these cell subsets to
produce IL-2 (Tentori et al., 1988b; Zlotnik et al.,
1992) and proliferate in its presence (Ceredig et al.,
1989; Toribio et al., 1989; Brooks et al., 1993),
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support the idea that IL-2 may drive the proliferation
and the differentiation of T-cell precursors. In fact,
the culture of T-cell progenitors with IL-2 promotes
their differentiation to TcRcq3, TcRy6, and NK cells
(Toribio et al., 1988; De la Hera et al., 1989; Brooks
et al., 1993; He and Kabelitz, 1995), and in vivo or in
vitro treatments that alter the IL-2/IL-2R complex
profoundly modify the T-cell maturation (Jenkinson
et al., 1987; Skinner et al., 1987; Tentori et al., 1988a;
Plum et al., 1990; Waanders and Boyd, 1990; Zufiiga-
Pflticke and Kruisbeek, 1990; Zufiiga-Pflticker et al.,
1990; Kroemer et al., 1991; Maslinski et al., 1992).
Furthermore, two waves of IL-2 mRNA production,
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which correlate well with the differentiation of two
waves of T-cell precursors (Jotereau et al., 1987;
Penit and Vasseur, 1989), have been reported during
fetal thymus development (Montgomery and Dallman
1991; Deman et al., 1994). Nevertheless, gene-
disruption experiments suggest that IL-2/IL-2R com-
plex is not required for the generation of normal cell
populations in the murine thymus (Schorle et al.,
1991; Suzuki et al., 1995; Willerford et al., 1995). In
addition, some authors reported the lack of CD25
expression on rat immature thymocytes (Takacs et al.,
1988; Kampinga and Aspinall, 1990). However, we
conclusively demonstrated the expression of IL-2Rc
chain on CD4-CD8-CD3- triple-negative (TN) cells
during rat thymus ontogeny. From this basis, we have
analyzed the effects of the addition of recombinant rat
IL-2 and the blockade of IL-2R by anti-CD25
antibodies on rat thymocyte maturation, using fetal
thymus organ cultures (FTOC) established from fetal
day-16 thymic lobes.
RESULTS
CD3
Expression of IL-2 Receptors and IL-2 mRNA
on Rat Fetal Thymocytes
The flow cytometrical analysis of rat fetal thymocytes
demonstrated that the highest proportion of IL-2Ra-
expressing thymocytes (20-30%) occurred at day 16
of gestation, when most thymocytes (-90%) corre-
sponded to CD3-CD4-CD8- cells (Figure a). At
the same stage, 20-25% of total thymic cells con-
tained IL-2 mRNA, as detected by in situ hybridiza-
tion (Figure lb).
Thymocyte Development in Rat FTOC
According to the acquisition of CD4, CD8, and
TcRcfi cell markers, rat FTOC mimicked the in vivo
T-cell development during rat thymus ontogeny. In
the first 4 days of culture, there was a gradual
decrease of the frequency of CD4-CD8- double-
negative (DN) cells, in correlation with the appear-
ance of immature CD4-CD8+, CD4+CD8 double-
positive (DP), and mature CD4+CD8 and
CD4-CD8 single-positive (SP) thymocytes (Figure
FIGURE (a) Expression of CD4, CD8, CD3, and CD25
antigens on fetal thymocytes from 16-day-old rat embryos. (b) IL-2
mRNA-containing cells (arrows) in thymocyte cytospin prepara-
tions from 16-day-old fetal rats.
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FIGURE 2 Evolution of control rat FTOC. Percentages of the
different thymic-cell subsets defined according to the coordinate
expression of CD4 and CD8. In these analyses, the subset
CD4-CD8 was subdivided into a CDS+TcRo/
high cell subpopula-
tion, obtained from gates in double stainings of CD8/TcRcq3, and a
CD8+TcRa/3
+/- cell subset, corresponding to immature CD8 cells
and CD8+TcRy6 thymocytes.IL-2 AND RAT T-CELL MATURATION 143
TABLE CD25 Expression on CD3- Thymocytes in Rat Fetal Thymus Organ Cultures
Day Day 3 Day 4 Day 5 Day 6 Day 7 Day 8 Day 12
6.72 _+ 2.03 5.40 0.67 3.92 0.60 7.43 _+ 1.33 5.55 _+ 0.71 3.92 0.53 4.58 0.67 6.66 0.60
Note: At different times of culture, thymocytes were stained with anti-CD25 and anti-CD3 antibodies, and the expression of CD25 was
analyzed in the CD3- cell compartment. Data are expressed as the mean +SEM from five to seven independent experiments.
2). As occurs in vivo (Vicente et al., manuscript
submitted), in those days of culture (5 to 7) equivalent
to the perinatal period, a new signal of expansion
occurred in rat FTOC, inducing a transient increase of
the DN-cell subset and its differentiation to immature
CD8+, DP, and mature SP thymocytes in the follow-
ing days (Figure 2). At that time, the percentage of
CD25+, which had gradually diminished during the
first 4 days of culture, sharply increased also in the
CD3- cell compartment (Table I).
Effects of IL-2 on the Development of Thymic
Major Cell Subpopulations
The number of cells per thymic lobe increased after
day of treatment with IL-2, remaining unchanged at
day 3 and even decreasing after 5 to 7 days of culture.
However, one more week of culture in the presence of
IL-2 increased again the thymic cellularity (Figure
3).
One day of culture with IL-2 basically induced an
increase in the numbers ofDN and CD4 cells (Figure
3). At day 3, the absolute numbers of the different
thymocyte subsets hardly changed, excepting for the
slight increase in mature CD8 thymocytes. This cell
subset remained unaltered after 5 days of treatment,
whereas the cell numbers of the rest of thymocyte
subpopulations decreased (Figure 3). By day 7 of
culture, the number of DN cells reached control
values and that of mature CD8 thymocytes increased.
Five more days of treatment with IL-2 induced a cell
expansion affecting to all thymocyte subsets, but in a
higher proportion to the DN-cell subpopulation (Fig-
ure 3).
Effects of Anti-CD25 Treatment on Thymocyte
Maturation
Anti-CD25 treatment was carried out by adding OX-
39 mAb, known by blocking the binding of IL-2 to
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FIGURE 3 Absolute numbers of different thymic-cell subpopulations in control (left bar) and IL-2-treated (right bar) FTOC for 1, 3, 5,
7, and 12 days. Thymocyte subsets were defined in double stainings by expresion of CD4, CD8 and TcRcq3. At each time point, the data
represented are the mean of three to five independent experiments. * p --< 0.05; **p -< 0.01; ***p --< 0.001 (Student’s test).144 A. VARAS et al.
TABLE II Cell Number of Thymocyte Subsets after Anti-CD25 Treatment
Phenotype
Time CD4-CD8- CD8+TcRcq3
+/- CD4+CD8 CD8+TcRafl
high CD4+CD8 Total
Day Control 0.58 0.11 0.50 0.09 0.06 0.01 0.03 0.01
OX-39 0.35 0.07 0.21 0.04 0.02 0.01 0.02 0.00
Day 3 Control 0.63 0.06 1.03 0.10 2.94 0.38 0.08 0.01 0.01 0.00
OX-39 0.61 0.06 0.76 0.12 1.18 0.32 0.06 0.01 0.01 0.00
Day 5 Control 1.10 0.30 0.66 0.22 6.46 1.43 0.43 0.07 0.13 0.06
OX-39 0.63 0.26 0.14 0.02 2.74 _+ 0.86 0.08 0.02 0.02 0.01
Day 7 Control 1.20 0.18 1.92 0.30 4.41 1.22 0.93 0.20 0.30 0.12
OX-39 0.88 0.19 0.42 0.11 0.62 0.16 0.15 0.03 0.06 0.01
Day 12 Control 0.76 0.16 2.22 0.44 20.05 4.64 1.90 0.52 1.01 0.30
OX-39 0.46 0.15 0.21 0.07 0.62 0.25 0.08 0.03 0.03 0.02
1.17 0.22
0.60 0.12
4.69 0.55
2.62 0.52
8.78 2.10
3.61 1.12
8.76 1.73
2.13 0.41
25.94 6.08
1.40 0.55
Note: Values represent the mean cell number (x 10-4) per lobe +SEM from three to six independent experiments.
ap __< 0.05;
bp < 0.01;
Cp 0.001 (Student’s test).
high-affinity IL-2 receptors (Paterson et al., 1987;
Somoza et al., 1990).
From the beginning of culture, the addition of OX-
39 mAb markedly inhibited viable cell yield in rat
FTOC. The reduction in thymic cellularity was
increasing to reach the highest effect after 12 days of
treatment (Table II).
In the continuous presence of OX-39, the absolute
numbers of all thymocyte subsets were always lower
than in control FTOC, being, at any time, the DN-cell
subpopulation the least affected by the treatment
(Table II). However, whereas the differentiation of
the second wave of T-cell progenitors was totally
inhibited, the cell precursors present in 16-day-old
fetal thymus partially matured, presumably because
some of them had already overcome the CD25 stage
(Table II).
DISCUSSION
The current data indicate that rat T-cell precursors
(TN cells) express IL-2 receptors, a fact previously
denied by other authors (Takacs et al., 1988; Kam-
pinga and Aspinall, 1990), although repeatedly
reported in mice, chickens, and humans (Ceredig et
al., 1985; Toribio et al., 1989; Zufiiga-Pflticker et al.,
1990; Fedecka-Brunner et al., 1991). In agreement
with our results, Brocke et al. (1987) found IL-2Rce-
beating cells in the thymus of 16-day-old fetal rats.
However, the immunohistological demonstration of
CD4 and CD8 expression in these thymic lobes was
misinterpreted, concluding that CD25 thymocytes
corresponded to mature thymocytes. Obviously, as
our results demonstrate, the rat thymic primordium
does not contain mature SP thymocytes but DN cells,
some of which, in progression to the DP-cell subset,
could already express CD4 and/or CD8 molecules in
their cytoplasm.
On the other hand, since IL-2 supports the growth
of rat thymocytes in FTOC, in a way that can be
blocked by anti-CD25 antibodies, IL-2 receptors
expressed on rat fetal thymocytes seem to be
functional. Contradictory results have been reported
on the ability of IL-2 to induce proliferative responses
in early thymocytes (Raulet, 1985; von Boehmer et
al., 1985; de la Hera et al., 1989; Toribio et al., 1989;
Brooks et al., 1993). Presumably, as recognized by
many authors, this induction is dependent on thymic
stromal cells or an intact thymic microenvironment,
as provided by organ cultures (De la Hera et al., 1989;
Ceredig et al., 1989; Zufiiga-Pflticker et al., 1990).
However, the continuous addition of IL-2 to rat FTOC
inhibits thymocyte growth and T-cell maturation, as
also reported in mouse organ cultures (Skinner et al.,
1987; Plum et al., 1990; Waanders and Boyd, 1990).
The generation of LAK cells has been pointed out to
be involved in the depletion of thymocytes and theIL-2 AND RAT T-CELL MATURATION 145
subsequent inhibition of T-cell differentiation (Skin-
ner et al., 1987). Alternatively, negative signals
transduced via the IL-2R in response to the IL-2
concentrations used in these experiments, which are
not continuously present in vivo, could also explain
these results (Waanders and Boyd, 1990). In fact, the
inhibition of cell proliferation (Suwa et al., 1995) and
the induction of apoptosis (Lenardo, 1991; Migliorati
et al., 1993) have been reported after IL-2 treat-
ment.
Our results obtained after IL-2 and anti-CD25
treatments, in agreement with previous findings in
both humans and mice (Toribio et al., 1988; Zufiiga-
Pflticker and Kruisbeek, 1990; Wilson et al., 1994)
also indicate that IL-2 promotes the differentiation of
thymic-cell precursors, as a consequence of its
capacity to stimulate cell proliferation.
Taken together, these results support a role for the
IL-2/IL-2R complex in the intrathymic maturation of
rat T-cell precursors.
MATERIALS AND METHODS
control cultures were done as described, the IL-
2-treated organ cultures were performed at a concen-
tration of 20 U/ml of recombinant rat IL-2 (Serotec,
UK), and the OX-39-treated cultures were carried out
in complete medium supplemented with 50% culture
supernatant from OX-39 hybridoma (anti-rat CD25).
In this case, control cultures made in parallel were
supplemented with 50% culture supernatant from an
irrelevant hybridoma (OX-14, anti-rat IgG2b).
Cell-Surface Staining
At various times through the culture period, a cell
suspension was made of thymic lobes, total cell count
was done, and the expression of CD4 (OX-38-PE),
CD8 (OX-8-FITC), TcRce/3 (R. 73-PE), CD3 (G4.18-
FITC), and CD25 (OX-39-PE) (all from Pharmingen,
USA) were analyzed. Flow cytometric analysis was
carried out on a FACScan (Becton-Dickinson, USA).
Dead cells were excluded from data acquisition on the
basis of forward/side scatter and propidium iodide
staining.
Animals
Wistar rats were maintained in our animal facilities.
Fetuses at day 16 of gestation were obtained from
timed pregnancies. The day of finding a vaginal plug
was designated day 0 of gestation.
Fetal Thymus Organ Cultures
Thymic lobes were aseptically removed from 16-day-
old rat embryos, trimmed of surrounding mechen-
chyme, and organ-cultured as follows. Four to six
thymic lobes were placed on the surface of poly-
carbonate filters (Millipore Ib6rica, Spain) supported
by stainless steel screen pieces. Lobes were cultured
in the central well of organ tissue culture dishes
(Becton-Dickinson, Spain) with 1 ml of RPMI 1640
medium (2 mM L-glutamine) supplemented with
sodium pyruvate (1 mM), streptomycin (100/xg/ml),
penicillin (100 U/ml) (all reagents: Gibco BRL,
France), and 10% FCS (Biosys, France). The cultures
were grown in a humidified incubator in 10% CO2 in
air at 37C, and the medium was replaced daily. The
In Situ Hybridization
Fetal thymocytes from day 16 of gestation were
isolated, cytospun onto slides, and fixed in paraf-
ormaldehyde (4% in PBS) during 30 min at room
temperature. After permeabilization with proteinase K
(2 /xg/ml) in Tris-EDTA during 20 min at room
temperature, cells were acetylated and dehydrated.
Hybridization was carried out at 37C in 5 SSC,
30% formamide, herring DNA (10 mg/ml), t-RNA
(10 mg/ml), and 5 /xg/ml of digoxigenin-labeled
cDNA probe for rat IL-2. Slides were washed in 30%
formamide in2 SSC at room temperature and 42C
during 5 and 15 min, respectively. Anti-digoxigenin
antibodies conjugated to alkaline phosphatase
(Boehringer Mannheim, Germany) were used for the
immunological detection according to the commercial
supplier’ s recommendations.
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